At the Ending Age-Related Diseases 2019 Conference in New York City, we had the opportunity to interview Dr. Justin Rebo from the drug discovery biotech company BioAge. BioAge is developing a drug discovery platform that uses machine learning and artificial intelligence to discover targets that have the potential to promote healthy lifespan (healthspan) by slowing…

Age-related changes to the signals sent and received by our cells travelling via the bloodstream are one of the hallmarks of aging. A team of researchers, including Drs. Irina and Michael Conboy, has published the results of a new study suggesting that rejuvenation might be achieved by the calibration of these signals found in the…

Today, we’re offering another talk from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology. Ronald Kohanski, Deputy Director of the Division of Aging Biology at the National Institute of Aging, gave a talk entitled…

We have known since the 19th century that young blood has surprising curative and rejuvenation abilities. It’s quite strange, but it happens to be true. In recent years, scientific efforts to understand what it is about young blood that causes rejuvenation have ramped up. We now know that young and old mice with surgically connected…

There has been a lot of hope and hype around blood transfusions and it being able to reverse aging recently. We decided to take a look at the science behind the idea and talk with a leading expert in the field to see what the reality was. Is blood the key to aging? Due to a…

© 2018 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

       Powered by MMD